Expertise in
4
conditions

Tim P. Somervaille

550 Wilmslow Road, 
Manchester, ENG, GB 
Expertise in
4
conditions
550 Wilmslow Road, 
Manchester, ENG, GB 

Overview

Tim Somervaille practices practicing medicine in Manchester, United Kingdom.

Mr. Somervaille is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Leukemia, Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

550 Wilmslow Road, Manchester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myeloproliferative Neoplasms)
A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myeloproliferative Neoplasms)
Enrollment Status: Completed
Publish Date: June 04, 2026
Intervention Type: Drug
Study Drugs: CPI-0610, Rituximab
Study Phase: Phase 1/Phase 2

69 Total Publications

Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.
Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.
Journal: British journal of haematology
Published: February 25, 2026

Frequently Asked Questions about Tim P. Somervaille

Is Tim P. Somervaille a top-rated expert for Myelofibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Tim P. Somervaille is classified as an Distinguished expert for Myelofibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tim P. Somervaille participate in research or clinical trials?

Yes. Tim P. Somervaille has published 69 articles and abstracts on conditions like Myelofibrosis. You can view a list of Tim P. Somervaille's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Somervaille's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile